KIDCOVE

A Detroit-based health system is enrolling children ages 6 months to 11 years old for Moderna’s COVID-19 vaccine study.

The University of Kentucky is beginning a new clinical trial to test the safety and effectiveness of the Moderna vaccine in children as young as 6-months-old, university officials said Wednesday.

A Detroit-based health system is enrolling children ages 6 months to 11 years old for Moderna’s COVID-19 vaccine study.

A Detroit-based health system is enrolling children ages 6 months to 11 years old for Moderna’s COVID-19 vaccine study.

Henry Ford Health System is enrolling children for a Moderna vaccine study. Participation is open to children ages 6 months to 11 years old.

Here's what's coming up on Local 4 News at 5.

(AP Photo/Michael Sohn, FILE)Moderna Inc. announced Tuesday it has started testing its mRNA-1273 vaccine candidate against COVID-19 in children ages 6 months to less than 12 years old. This is part of Moderna’s Phase 2/3 vaccine study called “KidCOVE” in which is intends to enroll about 6,750 pediatric participants in theU.S. Such trials in children already were underway in children aged 12 to 15. Both Pfizer and Moderna have started these trials and expect to have results from their trials in older children this summer. A vaccine for younger children has not been expected ready until early next year (2022).